Bristol Myers Squibb
Anant Madabhushi, PhD
Anant Madabhushi, PhD is a global leader in developing artificial intelligence to improve outcomes for patients with cancer and other diseases. Dr. Madabhushi joined Emory in 2022 and holds a primary faculty appointment in the Department of Biomedical Engineering, as well as secondary appointments in the Departments of Radiology and Imaging Sciences, Biomedical Informatics, and Pathology. Anant and his team, through a sponsored research agreement finalized in November 2022 with Bristol Myers Squibb, are investigating how to use their Artificial Intelligence (AI) tools to identify non-small cell lung cancer treatment patients that would respond to immunotherapy. The aim of Dr. Madabhushi’s research is to predict treatment response using radiomic, pathomic and combined radiomic and pathomic tools, with an overall goal to advance efforts to get the right treatment to the patients who will benefit the most.

More information: https://www.ott.emory.edu/about/annua...